What did Caire Inc. pay for MGC Diagnostics Holdings?

Caire Inc. acquired MGC Diagnostics Holdings for $170.0M in 2023, equivalent to 2.70x revenue. Target revenue was approximately $64.0M.

What does MGC Diagnostics Holdings do?

MGC Diagnostics Holdings is a medical devices business.

What multiple did Caire Inc. pay for MGC Diagnostics Holdings?

2.70x revenue, based on disclosed deal value of $170.0M and disclosed financials.

M&A TRANSACTION · 2023

MGC Diagnostics Holdings acquired by Caire Inc.

$170.0M· 2.70x revenue

Target

MGC Diagnostics Holdings

Acquirer

Caire Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$64.0M

EBITDA

—

Deal Value

$170.0M

EV/EBITDA

—

Context

This $170.0M acquisition of MGC Diagnostics Holdings by Caire Inc. sits in the medical devices sub-vertical. Caire Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the MGC Diagnostics Holdings acquisition.

Citation: ExitValue.ai. (2023). MGC Diagnostics Holdings acquired by Caire Inc.. https://exitvalue.ai/deals/mgc-diagnostics-holdings-acquired-by-caire-inc-fairness-opi